Teva Pharmaceutical Industries (TEVA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $2.5 billion.
- Teva Pharmaceutical Industries' Other Gross PP&E Adjustments fell 2405.25% to $2.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year decrease of 2405.25%. This contributed to the annual value of $2.5 billion for FY2025, which is 2405.25% down from last year.
- According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Other Gross PP&E Adjustments is $2.5 billion, which was down 2405.25% from -$342.0 million recorded in Q3 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Other Gross PP&E Adjustments peaked at $3.4 billion during Q4 2023, and registered a low of -$531.0 million during Q2 2021.
- Over the past 5 years, Teva Pharmaceutical Industries' median Other Gross PP&E Adjustments value was -$364.0 million (recorded in 2024), while the average stood at $448.0 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 58513.51% in 2021, then skyrocketed by 1694.92% in 2022.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Other Gross PP&E Adjustments stood at $2.8 billion in 2021, then increased by 10.82% to $3.1 billion in 2022, then increased by 11.15% to $3.4 billion in 2023, then decreased by 2.84% to $3.4 billion in 2024, then decreased by 24.05% to $2.5 billion in 2025.
- Its last three reported values are $2.5 billion in Q4 2025, -$342.0 million for Q3 2025, and -$358.0 million during Q2 2025.